Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Integrated Healthcare System01:20

Integrated Healthcare System

2.1K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
2.1K
International Nursing Organizations I01:23

International Nursing Organizations I

2.1K
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
2.1K
Statistical Analysis System (SAS)01:14

Statistical Analysis System (SAS)

693
SAS, short for Statistical Analysis System, is a powerful data analysis, management, and visualization tool. Developed by the SAS Institute in the early 1970s, SAS has evolved into a comprehensive software suite used across various industries for statistical analysis, business intelligence, and predictive modeling.
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
693
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences01:20

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences

1.1K
Inductively coupled plasma–mass spectrometry (ICP–MS) is a highly selective and sensitive technique for accurate elemental analysis. Though the analysis of ICP–MS mass spectra is comparatively straightforward, it is affected by spectroscopic and non-spectroscopic interferences. Spectroscopic interferences arise when the plasma contains ionic species with an m/z value the same as the analyte ion. Spectroscopic interference can be categorized as isobaric, polyatomic ions, and...
1.1K
Statgraphics01:10

Statgraphics

325
Statgraphics is a comprehensive statistical software suite designed for both basic and advanced data analysis. Originating in 1980 at Princeton University under Dr. Neil W. Polhemus, it was one of the pioneering tools for statistical computing on personal computers, with its public release in 1982 marking an early milestone in data science software. Over the years, it has evolved into a robust platform for data science, offering tools for regression analysis, ANOVA, multivariate statistics,...
325
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview01:19

Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview

1.6K
In inductively coupled plasma–mass spectrometry (ICP–MS), an inductively coupled plasma (ICP) torch is used as an atomizer and ionizer. Solid samples are dissolved and volatilized before being introduced into the high-temperature argon plasma, while solution samples are nebulized and passed through the high-temperature argon plasma. Plasma dissociates the analytes and ionizes their component atoms to form a mixture of positive ions and molecular species. The positive ions are then...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025†.

Human reproduction (Oxford, England)·2026
Same author

Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson's disease.

medRxiv : the preprint server for health sciences·2025
Same author

Corrigendum to 'Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy' Reproductive Biomedicine Online. 2023 Aug;47(2):103222.

Reproductive biomedicine online·2024
Same author

Evidence-based guideline: unexplained infertility†.

Human reproduction (Oxford, England)·2023
Same author

Oral Presentation Award Winner: LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?

European cardiology·2023
Same author

Biomechanical characteristics of the ovarian cortex in POI patients and functional outcomes after drug-free IVA.

Journal of assisted reproduction and genetics·2022
Same journal

Recombinant LH supplementation during ovarian stimulation modulates early embryo morphokinetics without affecting IVF outcomes in normal responders: a retrospective time-lapse study.

Journal of assisted reproduction and genetics·2026
Same journal

Redefining success in assisted reproductive technologies: the Embryo-Maternal-Offspring Continuum Framework.

Journal of assisted reproduction and genetics·2026
Same journal

Anti-Müllerian hormone and somatic ovarian function: a new perspective.

Journal of assisted reproduction and genetics·2026
Same journal

Rethinking supply chain disruption: a practical resilience framework for IVF laboratory quality management.

Journal of assisted reproduction and genetics·2026
Same journal

Another round, another chance: oocyte developmental competence and outcomes in second IVF attempts-the earlier, the better.

Journal of assisted reproduction and genetics·2026
Same journal

Fertility knowledge and family planning perspectives among female physicians: a cross-sectional study.

Journal of assisted reproduction and genetics·2026
See all related articles

Related Experiment Video

Updated: Dec 17, 2025

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
10:10

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds

Published on: November 13, 2021

9.2K

ALWAYS ICSI? A SWOT analysis.

E Bosch1, J J Espinós2,3, F Fabregues4

  • 1IVI RMA Valencia, Plaza de la Policía Local, 3, 46015, Valencia, Spain. Ernesto.Bosch@ivirma.com.

Journal of Assisted Reproduction and Genetics
|June 25, 2020
PubMed
Summary
This summary is machine-generated.

Intracytoplasmic sperm injection (ICSI) is widely used but lacks evidence for couples without male infertility. Its benefits, like preventing fertilization failure, are outweighed by risks such as higher costs and invasive procedures.

Keywords:
Assisted reproductionIn vitro fertilization (IVF)InfertilityIntracytoplasmic sperm injection (ICSI)PregnancySevere non-male factor

More Related Videos

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.6K
The Use of Induced Somatic Sector Analysis ISSA for Studying Genes and Promoters Involved in Wood Formation and Secondary Stem Development
09:54

The Use of Induced Somatic Sector Analysis ISSA for Studying Genes and Promoters Involved in Wood Formation and Secondary Stem Development

Published on: October 5, 2016

9.1K

Related Experiment Videos

Last Updated: Dec 17, 2025

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
10:10

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds

Published on: November 13, 2021

9.2K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.6K
The Use of Induced Somatic Sector Analysis ISSA for Studying Genes and Promoters Involved in Wood Formation and Secondary Stem Development
09:54

The Use of Induced Somatic Sector Analysis ISSA for Studying Genes and Promoters Involved in Wood Formation and Secondary Stem Development

Published on: October 5, 2016

9.1K

Area of Science:

  • Reproductive Medicine
  • Infertility Treatment
  • Assisted Reproductive Technology

Background:

  • Intracytoplasmic sperm injection (ICSI) is frequently employed to enhance reproductive outcomes.
  • Its use extends to couples without diagnosed male factor infertility, where indications remain debated.

Purpose of the Study:

  • To evaluate the advantages and disadvantages of ICSI in patients without a formal indication for the procedure.
  • To assess the evidence supporting ICSI use in non-male factor infertility cases.

Main Methods:

  • A SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis was conducted.
  • The analysis focused on the potential benefits and drawbacks of performing ICSI in specific patient groups.

Main Results:

  • ICSI is generally not justified for non-male factor infertile couples seeking in vitro conception.
  • Strengths include preventing total fertilization failure, while weaknesses involve increased technical difficulty, cost, and invasiveness.
  • Safety concerns associated with ICSI in this population warrant consideration.

Conclusions:

  • Evidence supporting the effectiveness of ICSI in patients without male factor infertility is currently insufficient.
  • Further large-scale, well-designed randomized controlled trials are necessary to establish clear indications for ICSI in non-male factor infertility.